Lee Health develops Enzymeact to treat digestive disorders
City-based pharmaceutical company Lee Health Domain has developed a unique pancreatic enzyme blend called Enzymeact, derived from vegetarian source to support pancreatic exocrine insufficiency.
image for illustrative purpose
Hyderabad: City-based pharmaceutical company Lee Health Domain has developed a unique pancreatic enzyme blend called Enzymeact, derived from vegetarian source to support pancreatic exocrine insufficiency.
The capsule contains amylase, protease and lipase which are derived from vegetarian source by microbial fermentation technology. Amylase aids in digestion by breaking down carbohydrates, protease helps in digestion of dietary proteins to allow absorption of amino acids and lipase breaks down fats in food to help better absorption in the intestine.
"People with pancreatic exocrine insufficiency will not be able to digest food properly due to lack of digestive enzymes, cystic fibrosis, removal of pancreas and long-term pancreatitis," said company's director Leela Rani. Vegetarian pancreatin works at a wider range of pH levels (pH 2.0 to 10.0) throughout the entire digestive tract, which is important for complete digestion of food. Whereas animal pancreatin have minimal effect to digest food as it is only active in the pH range between pH 2.0 to 3.0 and 7.0 to 9.0, she added.
